NEXENTIS TECHNOLOGIES INC. Earnings Per Share, Basic and Diluted
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Earnings Per Share, Basic and Diluted of -$2.06 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-31
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.56.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.46.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.69.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.31.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for fiscal 2021 was -$2.06.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for fiscal 2020 was -$1.05.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for fiscal 2019 was -$1.38.
- NEXENTIS TECHNOLOGIES INC. earnings per share, basic and diluted for fiscal 2018 was -$0.05.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$1.67 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$2.06 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | -$0.46 10-Q · filed 2021-11-15 | -$1.12 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.49 10-Q · filed 2021-11-15 | -$1.71 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||||
| 2021-06-30 | -$0.69 10-Q · filed 2021-08-16 | -$1.05 10-Q · filed 2021-08-16 | -$1.22 derived: net income ÷ weighted average shares · filed 2022-08-15 | -$1.52 derived: net income ÷ weighted average shares · filed 2022-08-15 | ||||
| 2021-03-31 | -$0.31 10-Q · filed 2021-05-18 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$0.72 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-05-16 | ||||
| 2020-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.80 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.05 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$0.28 10-Q · filed 2021-11-15 | -$0.04 10-Q · filed 2020-11-12 | -$0.67 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.92 10-Q · filed 2021-11-15 | -$0.13 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | -$0.40 10-Q · filed 2021-08-16 | -$0.06 10-Q · filed 2020-08-11 | -$0.65 10-Q · filed 2021-08-16 | -$0.09 10-Q · filed 2020-08-11 | ||||
| 2020-03-31 | -$0.25 10-Q · filed 2021-05-18 | -$0.04 10-Q · filed 2020-05-15 | ||||||
| 2019-12-31 | -$1.38 10-K · filed 2021-03-29 | -$0.20 10-K · filed 2020-03-30 | ||||||
| 2019-09-30 | -$0.05 10-Q · filed 2020-11-12 | -$0.10 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$0.14 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | -$0.05 10-Q · filed 2020-08-11 | -$0.09 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | -$0.04 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | -$0.05 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |